The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124090526 12409052 6 F 201603 20160823 20160526 20160826 EXP PHHY2016BR045443 NOVARTIS 60.01 YR F Y 72.00000 KG 20160826 MD BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124090526 12409052 1 PS AFINITOR EVEROLIMUS 1 Oral 1 DF OF 10 MG, QD SA822/SA835 22334 1 DF TABLET QD
124090526 12409052 2 C CALCIUM CALCIUM 1 Unknown UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124090526 12409052 1 Breast cancer metastatic
124090526 12409052 2 Bone disorder

Outcome of event

Event ID CASEID OUTC COD
124090526 12409052 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124090526 12409052 Abdominal discomfort
124090526 12409052 Abdominal pain
124090526 12409052 Anger
124090526 12409052 Aptyalism
124090526 12409052 Arthralgia
124090526 12409052 Arthropathy
124090526 12409052 Asthenia
124090526 12409052 Back pain
124090526 12409052 Blood calcium decreased
124090526 12409052 Blood urine present
124090526 12409052 Confusional state
124090526 12409052 Contusion
124090526 12409052 Cough
124090526 12409052 Decreased appetite
124090526 12409052 Dry mouth
124090526 12409052 Dysuria
124090526 12409052 Fluid intake reduced
124090526 12409052 Micturition frequency decreased
124090526 12409052 Mouth injury
124090526 12409052 Musculoskeletal stiffness
124090526 12409052 Nausea
124090526 12409052 Oral disorder
124090526 12409052 Pain
124090526 12409052 Pruritus generalised
124090526 12409052 Skin lesion
124090526 12409052 Sleep disorder due to general medical condition, insomnia type
124090526 12409052 Spinal osteoarthritis
124090526 12409052 Spinal pain
124090526 12409052 Stomatitis
124090526 12409052 Urinary tract infection
124090526 12409052 Urinary tract pain

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124090526 12409052 1 20160314 0
124090526 12409052 2 2013 0